Medical Nitrous Oxide Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2032

Nitrous oxide in medical use, commonly referred to as laughing gas, is a non-odorous, colorless gas having the chemical formula N2O. It is used in medical settings as general anesthetic, to induce and maintain anesthesia during surgical operations. Nitrous oxide is an inhalational agent used as a pain reliever and with other agents to provide anesthesia. Some examples are during childbirth, after an accident, and as part of palliative care. The onset of action is within half a minute and the duration is about a minute long.

Nitrous oxide functions by depressing the cardiovascular system and resulting in analgesia, anesthesia and euphoria. Furthermore, medical nitrous oxide is not only used anesthetically but also for pain management procedures such as emergency departments and outpatient centers. It is delivered by inhalation and chosen specifically for its rapid onset and offset of action, which is ideal for many medical procedures. The medical nitrous oxide market has been witnessing significant growth over the past few years due to its wide range of applications in medical procedures. Furthermore, the increasing prevalence of chronic diseases, rising surgical procedures, and the growing geriatric population worldwide are significant factors driving the market growth.

The medical nitrous oxide market is anticipated to reach USD XXX.X million by 2032 from USD XXX.X million in 2023, at a CAGR of XX.X% during the forecast period.

The expanding applications of nitrous oxide beyond traditional anesthesia are opening new avenues for market growth. Its use in pain management, procedural sedation, and other medical specialties is driving increased adoption and demand in the healthcare sector. Moreover, the development of advanced delivery systems and monitoring devices for nitrous oxide administration is expected to improve patient outcomes and safety standards in healthcare settings, which is expected to further boost the medical nitrous oxide market during the forecast period 2024-2032.

Growth Drivers:

The increasing number of surgical cases worldwide is the principal contributory factor for the medical nitrous oxide market. The increased occurrence of chronic diseases side by side with progresses in surgical procedure, requires anesthesia in surgeries. Nitrous oxide, or commonly referred to as laughing gas, is quick acting and is often blended with other anesthetic agents, creating a demand for medical nitrous oxide.

As populations all over the world age, they become more susceptible to several chronic diseases and age-related disorders that, as a result, escalate the demands for medical operations such as surgeries and medical therapies. With the population of older adults getting larger, especially in the developed world, there will be an increased need for nitrous oxide used as a general anesthesia as well as for pain management.

The growing usage of nitrous oxide beyond conventional anesthesia bolsters to the market growth. Nitrous oxide is more and more being used for pain management purposes, specifically in emergency rooms and outpatient clinics because of its quick action and minor side effects. Furthermore, its application in procedural sedation and other medical specialties more and more facilitates penetration into the healthcare industry.

The medical nitrous oxide market growth will be driven by technical progress in administration and monitoring. Developments in delivery systems and monitoring equipment’s increase the reliability and efficiency of nitrous oxide application during medical treatments. These innovations are not only capable of enhancing treatment outcomes but also encourage professionals in healthcare to implement them, which consequently leads to an increase in the market growth.

Medical Nitrous Oxide Segmentation:

By Type:

·         Gaseous Nitrous Oxide

·         Liquid Nitrous Oxide

By Application:

·         Cryosurgery

·         Surgical Insufflation

·         Anesthesia & Pain Relief

By End-User:

·         Hospitals

·         Academic & Research Institutes

·         Home Care Settings

·         Ambulatory Surgery Centers (ASCs)

By Region:

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

Medical Nitrous Oxide Market by Type Review:

Based on the type, the medical nitrous oxide market is segmented into two segments including gaseous nitrous oxide, and liquid nitrous oxide. On the basis of type, the liquid nitrous oxide segment is expected to dominate the market in terms of market share, while the gaseous nitrous oxide segment is predicted to grow at the highest rate in terms of CAGR during the forecast period.

Medical Nitrous Oxide Market by Application Review:

Based on the application, the market is segmented into cryosurgery, surgical insufflation, and anesthesia & pain relief. On the basis of application, the anesthesia & pain relief segment is expected to be the largest in terms of market share, while the surgical insufflation segment is predicted to grow at the highest rate in terms of CAGR during the forecast period.

Medical Nitrous Oxide Market by End-User Review:

Based on the end-user, the market is segmented into hospitals, academic & research institutes, home care settings, and ambulatory surgery centers (ASCs). On the basis of end-user, the hospitals segment is expected to be the largest in terms of market share, while the ambulatory surgery centers (ASCs) segment is predicted to grow at the highest rate in terms of CAGR during the forecast period.

Regional Outlook:

The medical nitrous oxide market research report offers detailed analysis and forecasts for five major regions i.e., North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa.

The North America region is forecasted to dominate the global medical nitrous oxide market followed by Asia Pacific, Europe, Latin America, and Middle East & Africa during the forecast period 2023-2030.

The North America region is anticipated to continue leading the global medical nitrous oxide market with an estimated market share of XX.X% in 2023. This regional medical nitrous oxide market is essentially propelled by the availability of major health facilities, research institutions, and pharmaceutical companies in the region. Moreover, North America is characterized by a large portion of its GDP being dedicated to health care spending, thus providing quality medical care and determining the need for anesthesia and other pain management solutions. Also, healthcare providers in North America focus on patients’ safety and comfort during medical procedures, resulting in a high demand for nitrous oxide as an anesthetic and analgesic agent, and this is expected to also augment the need for medical nitrous oxide in North America in the forecast period 2024-2032.

North America is one of the main regions of medical nitrous oxide market worldwide. It is because of its well-developed medical infrastructure, high medical technology adoption rate, and a large number of surgical procedures. This area is made up of the United States and Canada, each with a distinct influence on the market performance.

The increasing number of surgical procedures in North America is mainly responsible for the medical nitrous oxide market growth. For instance, the 2023 NCBI report forecasts that the number of Americans aged fifty or above with at least one chronic disease will rise from 71.522 million in 2020 to 142.66 million by 2050. Factors like increasing trends of chronic diseases and the innovations in surgery are responsible for the growing demand for anesthesia and pain management solutions which encompass nitrous oxide.

In addition, innovations in delivery systems and monitoring devices increase safety and effectiveness of nitrous oxide in a large number of medical procedures and this contributes to the growth of the market in the region during the forecast period 2024-2032.

Asia Pacific is the fastest growing region in terms of CAGR in the medical nitrous oxide market within the region. Medical nitrous oxide market in Asia Pacific is set to be the fastest growing market owing to improved healthcare infrastructure, rising medical tourism and increasing healthcare expenditure in countries like China, India and Japan. In addition, there is a rising acceptance of Western medical procedures, such as the use of nitrous oxide for anesthesia and pain management, fueling the market expansion. More so, growing economies of Asia Pacific are heavily putting in healthcare infrastructure development which is consequently resulting to increased access to surgical facilities and healthcare services, and it is anticipated that this would have a direct impact on market growth in Asia Pacific region during the forecast period 2024-2032.

Key Companies in Medical Nitrous Oxide Market:

The research report offers a competitive analysis of prominent companies operating in the medical nitrous oxide market. Some of the leading players profiled in the market research report include:

·         Air Liquide S.A.

·         Linde plc 

·         SOL Spa 

·         Norco, Inc.

·         Southern Gas Limited

·         Ellenbarrie Industrial Gases

·         CALOX, INC.

·         Steelman Gases Pvt. Ltd. 

·         NEXAIR

·         Oxygen & Argon Works Ltd.

·         Gulf Cryo

·         Chengdu Taiyu Industrial Gases Co., Ltd.

·         American Welding & Gas.

·         Asia Industrial Gases Pte. Ltd.

·         Other Players